U.S. Pharmaceuticals & Biotech Aktien - Top-Gewinner heute

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

AKTUALISIERT Jul 03, 2026

Entdecken Sie die U.S. (NYSE und NASDAQ) Top-Gewinner von heute. Diese Pharmaceuticals & Biotech Stocks haben den größten Anstieg der Marktkapitalisierung gegenüber dem vorherigen Handelstag verzeichnet.

709 Unternehmen

Unternehmen	Letzter Preis	1D Rückkehr	1J Rückkehr	Marktkapitalisierung	Analysten Ziel	Bewertung	Wachstum	Div. Rendite
JNJ	US$263.04	3.6%	68.6%	US$633.2b	US$257.50	30.1	8.3%	2.0%
LLY	US$1,213.91	1.9%	55.5%	US$1.1t	US$1,220.39	42.8	16.2%	0.6%
ABBV	US$261.07	4.0%	37.9%	US$461.3b	US$256.14	128.3	26.7%	2.7%
MRK	US$129.56	3.3%	60.1%	US$320.0b	US$131.11	35.8	19.4%	2.6%
VRTX	US$528.04	6.0%	14.9%	US$134.0b	US$548.69	30.9	13.0%	n/a
AMGN	US$374.15	3.5%	25.5%	US$201.9b	US$354.76	25.9	7.6%	2.7%
GILD	US$131.27	4.2%	17.5%	US$163.0b	US$157.67	17.7	20.3%	2.5%
TMO	US$523.44	2.0%	21.9%	US$194.5b	US$596.26	28.4	10.4%	0.4%
BMY	US$58.13	3.0%	23.9%	US$118.7b	US$63.00	16.3	-2.3%	4.3%
MRNA	US$79.76	10.0%	161.6%	US$31.6b	US$45.85	14.2	53.6%	n/a
REGN	US$654.27	4.7%	19.5%	US$66.6b	US$833.31	15.0	11.7%	0.6%
DHR	US$197.93	2.2%	-2.6%	US$140.1b	US$242.35	38.1	16.9%	0.8%
PFE	US$24.32	1.8%	-4.2%	US$138.6b	US$29.15	18.5	-1.8%	7.1%
ALNY	US$312.78	3.7%	-5.8%	US$41.8b	US$434.72	77.6	27.9%	n/a
TEVA	US$34.64	3.6%	103.6%	US$40.3b	US$40.90	25.8	16.2%	0%
RPRX	US$57.77	3.6%	58.8%	US$33.3b	US$59.25	31.0	38.8%	1.6%
INSM	US$111.60	4.3%	14.1%	US$24.2b	US$197.05	29.5	67.2%	n/a
ZTS	US$74.80	3.2%	-53.0%	US$31.4b	US$118.29	11.7	5.2%	2.8%
BIIB	US$216.12	3.0%	62.7%	US$31.9b	US$220.28	23.3	12.1%	n/a
BNTX	US$97.55	3.9%	-11.3%	US$24.7b	US$123.74	7.7	4.0%	n/a
SMMT	US$15.42	7.2%	-37.2%	US$12.0b	US$28.36	21.9	55.6%	n/a
ONC	US$297.65	2.4%	21.2%	US$33.1b	US$412.38	64.5	29.2%	n/a
ILMN	US$188.68	2.6%	87.2%	US$28.5b	US$153.26	33.5	9.8%	n/a
NBIX	US$174.26	3.9%	35.0%	US$17.5b	US$195.99	26.2	23.1%	n/a

Page 1 of 30